Private Equity Is Picking Up Biologics CDMO Avid Bioservices in $1.1B Acquisition
Avid Bioservices, a contract development manufacturing organization (CDMO) specializing in biologic drugs, is going private in an M&A deal that ...
Avid Bioservices, a contract development manufacturing organization (CDMO) specializing in biologic drugs, is going private in an M&A deal that ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
Throughout Illumina’s more than four-year saga to acquire liquid biopsy company Grail, it insisted the opposition from European regulators has ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.